Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

(2013) Keiichi Masaki et al.   HEPATOLOGY RESEARCH

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

(2012) Robert P. Myers et al.   LIVER INTERNATIONAL

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

(2011) Robert P. Myers et al.   HEPATOLOGY

Endpoints and clinical trial design for nonalcoholic steatohepatitis

(2011) Arun J. Sanyal et al.   HEPATOLOGY

The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®

(2011) M. Sasso et al.   Clinics and Research in Hepatology and Gastroenterology

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C

(2009) F. Negro et al.   JOURNAL OF VIRAL HEPATITIS

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

(2007) M. Yoneda et al.   DIGESTIVE AND LIVER DISEASE